Home/Filings/4/0001415889-23-003065
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-23-003065

CIK 0001583107other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 7:21 PM ET

Size

4.8 KB

Accession

0001415889-23-003065

Insider Transaction Report

Form 4
Period: 2023-02-20
GRAHAM RICHARD A
SVP, Development
Transactions
  • Tax Payment

    Ordinary Shares

    2023-02-20$10.44/sh12,057$125,875301,463 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:21 PM ET
Size
4.8 KB